Clearmind Medicine Adds Leading Israeli Clinical Site to Its Ongoing Clinical Trial for Alcohol Use Disorder
CMND Stock | USD 0.98 0.01 1.03% |
About 50% of Clearmind Medicine's shareholders are presently thinking to get in. The analysis of overall sentiment of trading Clearmind Medicine Common stock suggests that some investors are interested at this time. The current market sentiment, together with Clearmind Medicine's historical and current headlines, can help investors time the market. In addition, many technical investors use Clearmind Medicine Common stock news signals to limit their universe of possible portfolio assets.
Clearmind | Build AI portfolio with Clearmind Stock |
Vancouver, Canada, June 23, 2025 -- Clearmind Medicine Inc. , , a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced the addition of Tel Aviv Sourasky Medical Center , Tel Aviv, Israel, as an additional clinical site for its ongoing Phase IIIa clinical trial evaluating CMND-100, a proprietary MEAI
Read at finance.yahoo.com
![]() |
Clearmind Medicine Fundamental Analysis
We analyze Clearmind Medicine's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Clearmind Medicine using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Clearmind Medicine based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Retained Earnings
Retained Earnings Comparative Analysis
Clearmind Medicine is currently under evaluation in retained earnings category among its peers. Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
Clearmind Medicine Common Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Clearmind Medicine stock to make a market-neutral strategy. Peer analysis of Clearmind Medicine could also be used in its relative valuation, which is a method of valuing Clearmind Medicine by comparing valuation metrics with similar companies.
Peers
Clearmind Medicine Related Equities
DRMA | Dermata Therapeutics | 9.46 | ||||
JFBR | Jeffs Brands | 1.97 | ||||
VRAX | Virax Biolabs | 2.35 | ||||
SPRC | Scisparc | 5.01 |
Complementary Tools for Clearmind Stock analysis
When running Clearmind Medicine's price analysis, check to measure Clearmind Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearmind Medicine is operating at the current time. Most of Clearmind Medicine's value examination focuses on studying past and present price action to predict the probability of Clearmind Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearmind Medicine's price. Additionally, you may evaluate how the addition of Clearmind Medicine to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |